Medical societies to launch large-scale study on vein ... (study for investigational device exempti...)

Medical societies to launch large-scale study on vein filter use

Date:2/1/2013

study for investigational device exemption (IDE) study with HIPAA (Health Insurance Portability and Accountability Act) compliance. Study directors are Matthew S. Johnson, M.D., FSIR, Indiana University School of Medicine, Indianapolis, Ind., and David L. Gillespie M.D., FACS, University of Rochester School of Medicine and Dentistry, Rochester, N.Y. Most filter manufacturers have agreed to participate in the study.

According to the U.S. Surgeon General, between 350,000 and 600,000 people each year in the United States are affected by blood clots and between 100,000 and 180,000 people die of pulmonary embolism (a blood clot that travels to the lungs) each year. IVC filters are placed inside patients by vascular specialists to prevent blood clots from breaking free and traveling to the lungs or heart and causing a pulmonary embolism. FDA recommendations are that physicians remove the filters, which are designed to be retrievable, once the threat of pulmonary embolism has passed. The FDA warning said that all physicians were encouraged to consider the benefits and health risks of IVC filter removal for each patient.

Members of the IVC Filter Study Group Foundation board of directors are SVS President Peter Gloviczki, M.D., Mayo Clinic College of Medicine, Rochester, Minn. (president); SIR President Marshall E. Hicks, M.D., FSIR, University of Texas MD Anderson Cancer Center, Houston (vice president); SVS Executive Director Rebecca M. Maron, CAE (secretary); SIR Executive Director Susan E. Sedory Holzer, MA, CAE (treasurer); John A. Kaufman, M.D., MS, FSIR, Dotter Interventional Institute, Portland, Ore. (SIR representative); and Peter Lawrence, M.D., UCLA Medical Center, Santa Monica (SVS representative).

'/>"/>

Contact: Ellen Acconcia
eacconcia@sirweb.org
703-460-5582
Society of Interventional Radiology
Source:Eurekalert

0

GOOD

Page: 1 2
Related biology news :

1. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
2. Miniature pressure sensors for medical touch
3. Research!America says house funding levels for FY13 could undermine medical progress
4. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
5. Medical device, health professionals attend first national conference on value-driven engineering
6. Ultrasensitive biosensor promising for medical diagnostics
7. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
8. Tufts Medical Center researchers finds marker in premies saliva predicts readiness to feed by mouth
9. CDS Monarch Deploys DigitalPersona Strong Authentication Solutions for Secure Access to Electronic Medical Records
10. Nuisance seaweed found to produce compounds with biomedical potential
11. MADRID-MIT M+Vision Consortium hosts Biomedical Innovation Conference 2012

Post Your Comments:

(Date:6/18/2013)... of Calgary,s Faculty of Medicine have discovered a mechanism ... bacteria. Platelets, a component of blood typically associated with ... and upon detection, seal it off from the rest ... Nature Immunology this week, provide the science ... science community has known that platelets do participate in ...

(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...

(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...

Breaking Biology News(10 mins):Immunity mechanism discovered 2 Novel enzyme from tiny gribble could prove a boon for biofuels research 2 UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2

[0] Immunity mechanism discovered [0] Novel enzyme from tiny gribble could prove a boon for biofuels research [0] UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline

... SAN FRANCISCO, CAOctober 10, 2010Scientists at the Gladstone Institute ... associated with the storage of fat in the liver is ... (HCV). This discovery may offer a new strategy for treating ... throughout the world, and no vaccine is available to prevent ...

... The soils in large areas of the Southern Hemisphere, including ... drying up in the past decade, a group of researchers ... on a global basis. Most climate models have suggested ... land to the atmosphere, would increase with global warming. The ...

... on the way for millions of people on the East ... have reported a key advance in efforts to develop the ... major nuisance to homeowners and a devastating pest to some ... that infects a common weed and found that it shows ...

Cached Biology News:Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells 2 Land 'evapotranspiration' taking unexpected turn: huge parts of world are drying up 2 Land 'evapotranspiration' taking unexpected turn: huge parts of world are drying up 3 Progress toward first commercial repellent for East Coast's stinker 2

Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells Land 'evapotranspiration' taking unexpected turn: huge parts of world are drying up Progress toward first commercial repellent for East Coast's stinker

(Date:6/18/2013)... 2013 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its preliminary unaudited financial results for the fourth quarter ... 31, 2013. Fourth Quarter of Fiscal ... of fiscal 2013 increased by 33.3% to RMB133.0 million ...

(Date:6/18/2013)... 2013 In support of Swiss contributions ... General of Switzerland in New York is pleased to ... Tûranor PlanetSolar , to Manhattan. PlanetSolar is in ... 2013 tour with scientists on board from the University ... runs exclusively on energy from the sun and eliminates ...

(Date:6/18/2013)... 2013 (PRWEB) June 18, 2013 ... system in North America, has introduced AccountLinx Plus, ... and payroll records between ExakTime’s software and industry-leading ... ExakTime software setup and keeps employee databases up-to-date ... from a business’ current payroll software, directly into ...

(Date:6/18/2013)... 18, 2013 The Regulatory Affairs ... two new offices in Asia—one in Singapore and one ... as RAPS’ Pan-Asia office , serving the Asia ... focused on audiences within China. , The announcement comes ... with five Singapore government agencies to develop and implement ...

[0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City [0] ExakTime Introduces AccountLinx Plus [0] RAPS Opens Offices in Singapore and China

... ORLANDO, Fla. , May 11 GeneLink, Inc. (OTC Bulletin ... quarter ended March 31, 2010 . , , ... , , , ... Quarterly operating loss reduced by 14% over Q4 2009 Comparable quarter gross profit improvement ...

... LONDON , May 11, 2010 The subject ... point in the,scientific community. And as evidence comes to light of the continuing,beneficial ... UK has confirmed what many scientists already believe to,be the case - that ... , , , ...

... , May 11 EnVivo Pharmaceuticals today ... Phase IIb study of its EVP-6124 compound, a selective ... Alzheimer,s disease. The multi-center, dose ranging, placebo controlled, six-month ... is designed to determine the safety and efficacy ...

Cached Biology Technology:GeneLink Reports First Quarter Gains 2 Can Resveratrol Make You Smarter? 2 Can Resveratrol Make You Smarter? 3 Can Resveratrol Make You Smarter? 4 Can Resveratrol Make You Smarter? 5 EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124 2 EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124 3

GeneLink Reports First Quarter Gains Can Resveratrol Make You Smarter?EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124

...

... high PCR specificity *High PCR specificity ... enzyme with unique QIAGEN PCR Buffer ... provided by the stringent built-in hot ... Master Mix and simple reaction setup ...

... (NMPs) make up the internal structural framework of ... as DNA replication, RNA synthesis, and hormone receptor ... to be highly insoluble in vitro , ... soluble nuclear matrix proteins that can be detected ...

Request Info...

Biology Products:

Angiotensin Converting Enzyme Colorimetric Assay Kit from Alpco Diagnostics Hot StarTaq Master Mix Kit from QIAGEN Nuclear Matrix Protein ELISA Kit from Calbiochem T4 DNA Polymerase from Roche Applied Science